EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature

Valeria Cognigni iD, Ilaria Toscani, Simona D'Agnelli, Federica Pecci, Luisella Righi, Rossana Berardi, Marcello Tiseo

Translational Lung Cancer Research · 2025-04 · 14 (4) · 1441-1455

DOI: 10.21037/tlcr-24-755 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Lung Cancer Research, 2025-04. Verfasst von Valeria Cognigni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Small cell lung cancer (SCLC) is an aggressive disease commonly occurring in individuals with a history of heavy smoking. Despite recent approvals of chemotherapy and immunotherapy in the first-line treatment of extensive-stage SCLC, it maintains a poor prognosis. Moreover, only a small percentage of patients benefits from the addition of immunotherapy to platinum-based chemotherapy. The lack of significant progress in therapeutic options unrevealed the urgent need for a deeper understanding of tumor biology and easy-to-use predictive biomarkers, aiming to better tailor the treatment strategy. The aim of this review is to summarize recent evidence about the biology, molecular heterogeneity, as well as tumor microenvironment (TME) of SCLC and their forefront therapeutic implications.

Methods

A literature search was conducted using PubMed, focusing on articles published in English from 1981 to October 2024. Studies on SCLC biology and subclassification were selected for further analysis and integrated in the current narrative review. Key Content and Findings: SCLC entity implies four distinct molecular subtypes based on transcription factors expression, specifically achaete-scute homolog 1 (ASCL1), neurogenic differentiation 1 (NEUROD1), POU class 2 homeobox 3 (POU2F3), and yes-associated protein 1 (YAP1), reflecting the tumor heterogeneity in terms of gene expression, transcriptional profiles, immune infiltration, and treatment sensitivity. Recently, a new subgroup, "SCLC-I", has been proposed to replace the YAP1 subtype, showing higher responsiveness to immunotherapy. The TME, implying immune cell infiltration and their interactions with cancer cells, plays a crucial role in determining SCLC's sensitivity to immunotherapy.

Conclusions

Advances in SCLC molecular characterization and the development of targeted therapies against specific molecular pathways might improve patients' clinical outcome, supporting a more personalized approach to this complex disease.

Schlagwörter

Stichwörter der Autor:innen

Small cell lung cancer (SCLC)biomarkersmolecular heterogeneitymolecular subtypes

Autor:innen und Institutionen

  • Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
  • Medical Oncology Unit, Hospital of Piacenza, Piacenza, Italy.
  • Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Pathology Unit, Department of Oncology, University of Torino at San Luigi Hospital, Orbassano, Italy.

ORCID-Profile: Valeria Cognigni

Zitieren

APA

Cognigni, V., Toscani, I., D'Agnelli, S., Pecci, F., Righi, L., Berardi, R., & Tiseo, M. (2025). Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. Translational Lung Cancer Research, 14(4), 1441-1455. https://doi.org/10.21037/tlcr-24-755

Vancouver

Cognigni V, Toscani I, D'Agnelli S, Pecci F, Righi L, Berardi R, et al. Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. Translational Lung Cancer Research. 2025;14(4):1441-1455. doi:10.21037/tlcr-24-755

BibTeX
@article{Cognigni2025,
  author = {Cognigni, Valeria and Toscani, Ilaria and D'Agnelli, Simona and Pecci, Federica and Righi, Luisella and Berardi, Rossana and Tiseo, Marcello},
  title = {Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature},
  journal = {Translational Lung Cancer Research},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1441--1455},
  doi = {10.21037/tlcr-24-755}
}
Kostenlos starten →